Showing results (1-10 of 710) with videos related to
Sort By:
Pageof 71
RNA (New York, N.Y.)|August 24, 2019
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteinsJooyoung Lee, Haiwei Mou, Raed Ibraheim, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liverChunwei Zheng, Shun-Qing Liang, Bin Liu, et al.Nature Biotechnology|April 5, 2022
A split prime editor with untethered reverse transcriptase and circular RNA templateBin Liu, Xiaolong Dong, Haoyang Cheng, et al.Nature Biotechnology|March 30, 2023
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editingBowen Li, Rajith Singh Manan, Shun-Qing Liang, et al.Biorxiv : the Preprint Server for Biology|July 16, 2025
KRAS withdrawal in Cholangiocarcinoma leads to immune infiltration and tumor regressionYouwei Qiao, Matthew F Yee, Chaitanya N Parikh, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 3, 2025
KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor RegressionYouwei Qiao, Matthew F Yee, Chaitanya N Parikh, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2021
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airwayShun-Qing Liang, Christopher J Walkey, Alexa E Martinez, et al.Nature Methods|May 8, 2023
Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tagShun-Qing Liang, Pengpeng Liu, Karthikeyan Ponnienselvan, et al.Frontiers in Oncology|October 16, 2019
New Horizons in KRAS-Mutant Lung Cancer: Dawn After DarknessHaitang Yang, Shun-Qing Liang, Ralph A Schmid, et al.Nature Communications|April 10, 2021
Improved prime editors enable pathogenic allele correction and cancer modelling in adult micePengpeng Liu, Shun-Qing Liang, Chunwei Zheng, et al.Pageof 71